Nifedipin Retard Terapia (Nifedipine)

Nifedipine blocks L‑type calcium channels on vascular smooth muscle and cardiac cells, preventing calcium entry that triggers contraction. This leads to arterial relaxation, reduced peripheral resistance, lower blood pressure, and decreased myocardial oxygen demand, helping to control angina and improve peripheral circulation.

The specific dose and dosing schedule of Nifedipin Retard Terapia are determined by the prescribing clinician based on the patient’s condition, response, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for nifedipine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nifedipine belongs to the calcium channel blocker class, offering a distinct mechanism of arterial vasodilation compared with ACE inhibitors, beta‑blockers or diuretics. Its extended‑release formulation provides steady plasma levels, which can be advantageous for patients needing consistent blood pressure control and angina relief.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and heat sources to maintain stability and potency throughout the shelf life.

The medication is taken orally as an extended‑release tablet. It should be swallowed whole with a glass of water, preferably at the same time each day, and not crushed, chewed, or split, to preserve the controlled‑release properties.

Serious adverse events, though rare, include severe hypotension, myocardial infarction, and liver dysfunction. Patients should seek immediate medical attention if they experience sudden dizziness, chest pain, or signs of liver injury such as jaundice or dark urine.

Individuals with known hypersensitivity to nifedipine or any component of the formulation should avoid the product. Caution is also advised for patients with severe aortic stenosis, unstable heart failure, or those taking contraindicated medications; a healthcare professional must evaluate suitability.